An official website of the United States government
07/24/2020: Lab Advisory: Updated LOINC In-Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Test Results
Audience: Clinical Laboratory Professionals
Subject: Lab Advisory: Updated LOINC In-Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Test Results
Level: Laboratory Advisory
On Friday, July 24, CDC updated the LOINC In Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Tests to include new data elements in the “LOINC Mapping” tab:
- Testkit Name ID
- Testkit Name ID Type
- LOINC Order Code
- LOINC Order Code Long Name
- LOINC Version ID
Additionally, the updated version includes a new “LOINC Mapping Columns” tab, which contains the column descriptions from the LIVD Spreadsheet Guidance document.
Required Data Elements:
CDC’s update aligns with the U.S. Department of Health and Human Services (HHS) guidance related to laboratory test result reporting as specified in the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The additional data elements provided in the LIVD mapping are required for the transmission of complete SARS-CoV-2 laboratory testing data to the CDC or the HHS Secretary’s designee.
Online resources:
- SARS-CoV-2 LOINC codes and Basics
- SNOMED CT Basics
- FDA FAQs on Diagnostic Testing for SARS-CoV-2
- FDA Emergency Use Authorizations
- NIH Value Set Authority for COVID-19
- Interoperability Standards Advisory for COVID-19 Pandemic
- Clinical Laboratory COVID-19 Response Weekly Calls
- CDC’s Laboratory Outreach Communication System (LOCS)
- COVID-19 Information for Laboratories
- CDC COVID-19 website
- CDC COVID-19 Testing by Laboratories: Q & A
- Reporting COVID-19 Laboratory Data
If you have any questions, please contact us at LOCS@cdc.gov.
Thank you,
The Laboratory Outreach Communication System
Laboratory Outreach Communication System | Division of Laboratory Systems (DLS)
Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)
Centers for Disease Control and Prevention (CDC)